| Literature DB >> 35683606 |
Lourdes Vicent1, Raquel Luna1, Manuel Martínez-Sellés2,3,4.
Abstract
Infective endocarditis in children is a rare entity that poses multiple challenges. A history of congenital heart disease is the most common risk factor, although in recent years, other emerging predisposing conditions have gained relevance, such as central venous catheters carriers or children with chronic debilitating conditions; cases in previously healthy children with no medical history are also seen. Diagnosis is complex, although it has improved with the use of multimodal imaging techniques. Antibiotic treatment should be started early, according to causative microorganism and risk factors. Complications are frequent and continue to cause significant morbidity. Most studies have been conducted in adults and have been generalized to the pediatric population, with subsequent limitations. Our manuscript presents a comprehensive review of pediatric infective endocarditis, including recent advances in diagnosis and management.Entities:
Keywords: children; infective endocarditis; pediatrics
Year: 2022 PMID: 35683606 PMCID: PMC9181776 DOI: 10.3390/jcm11113217
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Predisposing factors of infective endocarditis in children.
| Congenital Heart Disease | Vulnerable: Acquired Risk Factors | Previous Healthy |
|---|---|---|
| Cyanotic disease | Immunodeficiency | Dental procedures |
| Recent cardiac surgery | Cancer | Skin infections/lacerations |
Figure 1Janeway lesions in a 15-year-old adolescent with aortic valve infective endocarditis: hemorrhagic macules of the palms and soles that are due to septic emboli.
Figure 2A 16-year-old woman with tetralogy of Fallot and pulmonary atresia. Contegra conduit endocarditis by Streptococcus sanguis.
Figure 3A 16-year-old male with native tricuspid valve infective endocarditis due to Viridans Streptococcus. Previous history of CHD with restrictive perimembranous ventricular septal defect, secondary moderate–severe tricuspid regurgitation, and septic pulmonary embolisms.
Etiology of pediatric infective endocarditis according to the history of congenital heart disease (CHD) [10].
| No CHD | CHD |
|---|---|
Modified Duke criteria for diagnosis of infective endocarditis.
| Infective Endocarditis–Modified Duke Criteria * |
|---|
| Major criteria |
| Blood culture positive for typical microorganism (i.e., |
| Echocardiogram showing valvular vegetation |
| Minor criteria |
| Predisposing cardiac condition or injection drug use |
| Temperature > 38 °C |
| Embolic phenomena |
| Immunologic phenomena (glomerulonephritis, Osler’s nodes, Roth’s spots, and rheumatoid factor) |
| Positive blood culture not meeting above criteria |
* Definite IE: 2 major OR 1 major + 3 minor criteria. Possible IE: 1 major + 1 minor OR 3 minor criteria.
Figure 4Infective endocarditis in a 13-year-old boy with bicuspid aortic valve due to Aggregatibacter aphrophilus (HACEK group). (A) Apical 5-chamber view showing aortic valve vegetation. (B) Paraesternal long axis with aortic valve showing aortic valve thickening and vegetation.
Differential diagnoses of infective endocarditis in children.
| Infective Endocarditis Differential Diagnosis in Children |
|---|
| Familial Mediterranean Fever, juvenile rheumatoid arthritis |
| Rheumatic fever |
| Acute myocarditis |
| Pneumonia |
| Kawasaki disease |
| Acute myelocytic leukemia |
| Bacterial meningitis |
| Childhood vasculitis |
| Rheumatic diseases |
| Infections complicated with septicemia (i.e., soft tissues, urinary, etc.) |
Predisposing factors for complications in children with infective endocarditis.
| Risk Factors for IE Complications |
|---|
| Size of the vegetation > 1 cm |
| Younger age, prematurity |
| No known heart disease |
| Left-sided valvular lesion |
| Complex cyanotic congenital heart disease |
| Higher white blood cell counts and plasma C-reactive protein |
| Persistent fever |
Antimicrobial regimens according to etiology in pediatric infective endocarditis (IE) with the recommended week (w) duration.
| Causative Microorganism | Antibiotic Regimen | |
|---|---|---|
| Unknown agent |
| |
|
|
|
|
|
Native: PVE: | ||
|
|
|
|
|
Native: PVE *: |
Native: PVE: | |
| Enterococcus | Non high-level aminoglycoside resistance | High-level aminoglycoside resistance |
| HACEK group | Alternative regimen | |
| Cardiac surgery + antifungal agents | Chronic suppressive therapy with oral fluconazole lifelong in patients who cannot undergo surgical resection | |
HACEK: Hemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species. PVE: Prosthetic Valve Endocarditis.
Indications for surgical intervention in pediatric infective endocarditis.
| Indications for Surgery in Patients with Infective Endocarditis |
|---|
| Valve dysfunction resulting in symptoms of heart failure |
| Left-sided IE caused by |
| Complications: heart block, annular or aortic abscess, pseudoaneurism or fistulae |
| Persistent infection (persistent bacteremia, fever > 5–7 days despite appropriate antimicrobial therapy) |
| Relapsing infection (recurrence of bacteremia after a complete antibiotic course) |
| Persistent vegetation and recurrent emboli despite appropriate antimicrobial therapy |
| Persistent fever |
Current indications for antibiotic prophylaxis to prevent infective endocarditis (IE).
| Previous IE |
|---|
| Previous cardiac surgery and prosthetic material for cardiac valve or congenital heart defects repair |
| Prosthetic valves |
| Cyanotic congenital heart disease |
| Heart transplant with heart valve disease |
| Mechanical circulatory support |